Cystic fibrosis: Part 1.
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology; D001798:Blood Proteins / Q000378:metabolism; D040501:Calgranulin A; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications / Q000453:epidemiology / Q000235:genetics / Q000276:immunology / Q000503:physiopathology; D005088:Exocrine Glands / Q000378:metabolism; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008171:Lung Diseases / Q000209:etiology / Q000473:pathology; D008297:Male; D009093:Mucus / Q000032:analysis; D011660:Pulmonary Heart Disease / Q000209:etiology; D012129:Respiratory Function Tests; D012138:Respiratory Therapy; D012140:Respiratory Tract Diseases / Q000209:etiology
D000900:Anti-Bacterial Agents; D001798:Blood Proteins; D040501:Calgranulin A; C007065:ciliary dyskinesia factor; C026422:cystic fibrosis serum factor